Author:
Kumbrink Joerg,de la Cueva Ana,Soni Shefali,Sailer Nadja,Kirsch Kathrin H.
Funder
National Cancer Institute
National Institutes of Health
Susan G. Komen for the Cure
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Kumbrink J, Kirsch KH. Targeting Cas family proteins as a novel treatment for breast cancer, breast cancer—current and alternative therapeutic modalities. Esra Gunduz and Mehmet Gunduz (Ed), InTech. 2011;ISBN: 978-953-307-776-5:37-62.
2. Tikhmyanova N, Little JL, Golemis EA. CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci. 2010;67(7):1025–48.
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.
4. Kumbrink J, Soni S, Laumbacher B, Loesch B, Kirsch KH. Identification of novel Crk-associated substrate (p130Cas) variants with functionally distinct focal adhesion kinase binding activities. J Biol Chem. 2015;290(19):12247–55.
5. Cabodi S, Pilar Camacho-Leal M, Di Stefano P, Defilippi P. Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer. 2010;10(12):858–70.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献